Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03011710
Other study ID # epidacute-ecig-2015
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2015
Est. completion date November 22, 2023

Study information

Verified date July 2022
Source Semmelweis University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Electronic cigarettes are battery-powered vaporizers which have a similar feel to tobacco smoking. They do not produce cigarette smoke but rather an aerosol, which is frequently referred to as vapor. E-cigarettes are marketed as less harmful alternatives to smoking. Use and awareness of these devices has grown exponentially in recent years, with millions of people currently using them. The benefits and risks of electronic cigarette use are uncertain. There is no research on the acute oral effects of electronic cigarette in the scientific literature and no hungarian epidemiological survey has been performed in this topic. Regulation of electronic cigarettes varies across countries in the European Union, ranging from no regulation to banning them entirely. The investigators research could help to integrate the regulation of this device in Hungary and in the EU as well. The measurement of acute oral effects of e-cigarette and a hungarian epidemiological survey would be novel in this topic.


Description:

The epidemiological survey is performed with online questionnaires, which are published on e-cigarette-selling websites and on other forums dealing with this topic. The main outcome of interest was whether or not e-cigarette use helped people to quit smoking or reduce the number of conventional cigarettes. Participants were also asked about the reason for starting e-cigarette use. Nationality, habitation, citizenship status were included as demographic predictors in analyses. Measurements of acute oral effects before and after using electronic cigarette with nicotine, without nicotine, conventional cigarette and placebo device: - measurement of exhaled CO changes by Smokerlyzer piCO - measurement of saliva MMP-8 by PerioSafe Home - measurement of saliva pH, buffering capacity, and flow rate changes by Saliva Check Buffer Kit (GC) - measurement of oral mucosal blood flow changes by Perilam PSI System High Resolution (LASCA method)


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date November 22, 2023
Est. primary completion date November 22, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 49 Years
Eligibility Inclusion Criteria: - age: 19-49 years - signed consent form - smoking regularly e-cigarette and/or conventional cigarette for > half year Exclusion Criteria: - not pregnant and not planning pregnancy in the next 6 month - BMI index < 30 - no severe parodontal disease - no acute illness in the last 2 weeks - no chronic disease (eg.: diabetes) - no diet which can influence the oral pH

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ProVari v2.5 (E-cigarette)
An electronic cigarette or e-cigarette is a handheld electronic device that vaporizes a flavored liquid. The user inhales the vapor. The fluid in the e-cigarette, called e-liquid, is usually made of nicotine, propylene glycol, glycerine, and flavorings.
Marlboro Gold (Conventional cigarette)
Conventional cigarette
Cigarette tip
Placebo device

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Semmelweis University

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in blood flow after vaping/smoking The blood flow changes are measured by Laser Speckle Contrast Analyzer (LASCA) before (baseline) and after vaping/smoking. baseline, immediately after smoking/vaping, and 15 minutes after smoking/vaping
See also
  Status Clinical Trial Phase
Completed NCT05477342 - Reducing Nicotine Addiction in Adolescent Smokers N/A
Recruiting NCT03191825 - Online Lapse Management Intervention N/A
Recruiting NCT03194919 - Negotiating a Quit Date or Not in Online Interventions N/A
Completed NCT03719391 - United States Pre-Market Tobacco Application Pharmacokinetics N/A
Completed NCT05538702 - Acute Oral Effects of Heated Tobacco Products N/A
Completed NCT02723162 - Translational Neuropsychopharmacology Research of Nicotine Addiction Phase 2
Completed NCT03194958 - Helping Poor Smokers Quit N/A
Completed NCT03593239 - Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers N/A
Completed NCT04830384 - Evaluation of LLLT/Music for Smoking Cessation N/A
Completed NCT02367391 - Penn State TXT2Quit Study N/A
Recruiting NCT05665465 - Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking Early Phase 1
Completed NCT04805515 - Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior N/A
Completed NCT03700112 - Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods. N/A
Terminated NCT02986711 - Penn State TXT2STAYQUIT Study- a Texting Study to Help Hospitalized Smokers Stay Quit N/A
Recruiting NCT05224154 - Re-Connect Application for Smoking Cessation N/A
Completed NCT03492463 - The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products Phase 2
Withdrawn NCT03473483 - Cigarette Harm Reduction With Electronic Cigarette Use N/A
Completed NCT04379388 - Improving Smoking Cessation in Socioeconomically-Disadvantaged Young Adults N/A
Active, not recruiting NCT04163081 - The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments N/A